GNI Group Beheer
Beheer criteriumcontroles 2/4
GNI Group's CEO is Ying Luo, appointed in Jun 2009, has a tenure of 15.42 years. total yearly compensation is ¥194.05M, comprised of 30.1% salary and 69.9% bonuses, including company stock and options. directly owns 2.89% of the company’s shares, worth ¥4.38B. The average tenure of the management team and the board of directors is 8.6 years and 1.7 years respectively.
Belangrijke informatie
Ying Luo
Algemeen directeur
JP¥194.1m
Totale compensatie
Percentage CEO-salaris | 30.1% |
Dienstverband CEO | 15.4yrs |
Eigendom CEO | 2.9% |
Management gemiddelde ambtstermijn | 8.6yrs |
Gemiddelde ambtstermijn bestuur | 1.7yrs |
Recente managementupdates
Recent updates
After Leaping 48% GNI Group Ltd. (TSE:2160) Shares Are Not Flying Under The Radar
Sep 20GNI Group's (TSE:2160) Shareholders Should Assess Earnings With Caution
Aug 27GNI Group Ltd. (TSE:2160) Stock's 37% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Aug 06Investors Continue Waiting On Sidelines For GNI Group Ltd. (TSE:2160)
Jun 20Is GNI Group (TSE:2160) Using Too Much Debt?
Apr 12News Flash: Analysts Just Made An Incredible Upgrade To Their GNI Group Ltd. (TSE:2160) Forecasts
Mar 19Further Upside For GNI Group Ltd. (TSE:2160) Shares Could Introduce Price Risks After 40% Bounce
Feb 28Analyse CEO-vergoeding
Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
---|---|---|---|
Jun 30 2024 | n/a | n/a | JP¥7b |
Mar 31 2024 | n/a | n/a | JP¥10b |
Dec 31 2023 | JP¥194m | JP¥58m | JP¥8b |
Sep 30 2023 | n/a | n/a | JP¥2b |
Jun 30 2023 | n/a | n/a | JP¥1b |
Mar 31 2023 | n/a | n/a | JP¥35m |
Dec 31 2022 | JP¥167m | JP¥33m | JP¥388m |
Compensatie versus markt: Ying's total compensation ($USD1.27M) is above average for companies of similar size in the JP market ($USD921.72K).
Compensatie versus inkomsten: Ying's compensation has been consistent with company performance over the past year.
CEO
Ying Luo (59 yo)
15.4yrs
Tenure
JP¥194,053,000
Compensatie
Dr. Ying Luo, Ph.D. is Chairman, Chief Executive Officer and President of Cullgen Inc. He is a Director at Gyre Therapeutics, Inc. since December 26, 2022 and also its Chairman of the Board. He served as a...
Leiderschapsteam
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
CEO, President | 15.4yrs | JP¥194.05m | 2.89% ¥ 4.4b | |
Co-Founder | 23.8yrs | geen gegevens | geen gegevens | |
Co-Founder | 23.8yrs | geen gegevens | geen gegevens | |
Co-Founder | 23.8yrs | geen gegevens | geen gegevens | |
Executive officer | 1.1yrs | geen gegevens | 0.0080% ¥ 12.1m | |
Executive Officer | less than a year | geen gegevens | geen gegevens | |
VP & Executive Officer | 1.1yrs | geen gegevens | 0.098% ¥ 149.1m | |
Executive Officer & Chief Business Development Officer | 1.8yrs | geen gegevens | geen gegevens |
8.6yrs
Gemiddelde duur
62yo
Gemiddelde leeftijd
Ervaren management: 2160's management team is seasoned and experienced (8.6 years average tenure).
Bestuursleden
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
CEO, President | 19.4yrs | JP¥194.05m | 2.89% ¥ 4.4b | |
Executive officer | less than a year | geen gegevens | 0.0080% ¥ 12.1m | |
Executive Officer | 1.7yrs | geen gegevens | geen gegevens | |
Director | 11.7yrs | geen gegevens | 0.0042% ¥ 6.3m | |
Independent External Director | 16.4yrs | geen gegevens | geen gegevens | |
Independent Outside Director | 1.7yrs | geen gegevens | geen gegevens | |
Independent Outside Director | 1.7yrs | geen gegevens | 0.15% ¥ 233.8m | |
Independent Outside Director | less than a year | geen gegevens | 0.020% ¥ 30.2m |
1.7yrs
Gemiddelde duur
60.5yo
Gemiddelde leeftijd
Ervaren bestuur: 2160's board of directors are not considered experienced ( 1.7 years average tenure), which suggests a new board.